Gastroenterology Abstracts On The Go
A monthly deep dive into the most influential and practice-shaping publications in Gastroenterology. Each episode breaks down key studies, highlights clinical implications, and offers clear, evidence-based insights for busy clinicians, trainees, and researchers. Whether it’s landmark trials, emerging therapies, or updated guidelines, this podcast brings the latest GI literature to life—helping listeners stay current, think critically, and apply new knowledge at the bedside.
Episodes
Gastroenterology April 2026 Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease
This study evaluates how effectively a specific blood biomarker, phosphatidylethanol (PEth), can forecast severe liver complications in individuals at risk for alcohol-related liver disease. While traditional noninvasive tests primarily measure existing liver scarring or fibrosis, this research demonstrates that tracking PEth levels provides a distinct, independent layer of prognostic data regardi
Gastroenterology April 2026 Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course Severity
This study investigates whether a person’s inherited predisposition to inflammatory bowel disease (IBD) also determines how aggressively the condition will progress. By analyzing thousands of patients, researchers found that individuals with a higher genetic burden faced significantly more hospitalizations, surgeries, and a greater need for intensive drug therapies. While the severity of Crohn’s d
Gastroenterology April 2026 Faecalibacterium prausnitzii Induces an Anti-inflammatory Response and a Metabolic Reprogramming in Human Monocytes
This study explores how a common gut bacterium, Faecalibacterium prausnitzii, protects human health by directly influencing immune cells to reduce inflammation. Researchers discovered that this specific microbe triggers a dose-dependent production of IL10, a vital anti-inflammatory signal, within monocytes located in both the blood and the intestines. Unlike other bacteria, F. prausnitzii achieves
Gastro Hep Advances March 2026 Iron Deficiency Anemia Is Associated With Gastric Intestinal Metaplasia in Patients With Helicobacter pylori Infection
This study investigates the medical correlation between iron deficiency anemia and the development of gastric intestinal metaplasia, a condition considered a precursor to stomach cancer. By examining a cohort of patients infected with H. pylori, researchers discovered that those suffering from low iron were significantly more likely to exhibit these precancerous lesions. The risk was particularly
Gastroenterology March 2026 Mutational Landscape of Colorectal Tumors From Individuals With Unexplained Adenomatous or Serrated Colorectal Polyposis
This research investigates the genetic origins of colorectal polyps in patients who lack a known hereditary diagnosis for their condition. By analyzing the somatic mutations and molecular signatures of nearly 300 tumors, the study highlights how specific genetic drivers like APC and BRAF distinguish different types of growths. A key discovery is that serrated polyps appear molecularly closer to he
Gastroenterology February 2026 Gastric Organoid-Based Ectopic and Orthotopic In Vivo CRISPR Screening for Tumor Suppressors in Gastric Cancer
This research utilizes CRISPR-Cas9 gene-editing technology to identify specific genes that normally prevent the development of stomach cancer. By testing thousands of potential targets within mouse-derived organoids, the researchers discovered that the loss of genes like Pten and those in the TGF-ß pathway significantly accelerates tumor growth and creates early-stage cancer lesions. The study fur
Gastroenterology February 2026 AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review Description
The American Gastroenterological Association developed these guidelines to standardize the complex care required for adults hospitalized with severe inflammatory bowel disease. By addressing thirteen critical clinical areas, the text provides a framework for prompt evaluation, ranging from the use of biomarkers and endoscopy to the proactive prevention of venous thromboembolism. The recommendation
Lancet February 2026 Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study
This study highlights a critical gap in global health policy, as liver diseases like MASLD and MASH are currently missing from the World Health Organization’s primary strategies for non-communicable diseases. By surveying hundreds of international experts, the research establishes a strong global consensus on fifteen essential interventions that should be prioritized for their high impact and feas
Lancet February 2026 Cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain long-term drug-free remission in paediatric Crohn's disease (CD-HOPE): an open-label, endpoint-blinded, randomised controlled trial
This research study investigated whether specialized liquid diets could successfully maintain long-term clinical remission in children with Crohn's disease without the need for traditional pharmaceutical drugs. Researchers compared two distinct methods: a cyclic approach involving two-week bursts of an exclusive liquid diet every two months, and a partial approachwhere patients consumed a smal
Lancet February 2026 Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort study
This study investigated whether surgical removal of the appendix could help patients with severe ulcerative colitis who no longer respond to standard biological medications. By comparing this procedure to the alternative of switching to JAK inhibitor drugs, researchers found that patients who underwent an appendicectomy were significantly more likely to achieve long-term clinical remission. Beyond
JAMA February 2026 Prevalence of Colorectal Cancer Screening Among Latino Adults Following the Medicaid Eligibility Amendment Expansion
This research study investigates whether broadening Medicaid eligibilityto include low-income adults regardless of their immigration status helps improve preventative healthcare outcomes. By comparing patients in states that adopted these inclusive policies against those that did not, the authors found a significant increase in colorectal cancer screenings among various Latino and Latina subgroups
BMJ Gut February 2026:Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma
This research investigates why most liver cancer patients fail to respond to standard combined immunotherapy, identifying a protein called galectin-4as a primary culprit behind treatment resistance. By stabilizing metabolic enzymes and triggering specific chemical signals, galectin-4 forces the tumor into a state of metabolic adaptation that effectively shields it from the immune system. This proc
BMJ GUT February 2026:Towards optimising and standardising donor screening for faecal microbiota transplantion.
To address the lack of uniform evidence-based standards, this article proposes a rationalized framework for screening stool donors to ensure the safety of fecal microbiota transplants. The authors conducted a comparative review of existing guidelines and utilized an expert Delphi process to balance the prevention of pathogen transmission with the need to maintain an adequate donor supply. By advoc
Lancet Gastroenterology Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial.Background
The SHINE-1 study explored the potential of mirikizumab, a specialized antibody treatment, for children and adolescents suffering from moderate-to-severe ulcerative colitis who had failed previous therapies. By blocking a specific inflammatory protein known as IL-23, the drug aimed to reduce intestinal damage and provide long-term relief through a sequence of intravenous and subcutaneous doses. Th
JAMA Gastroenterology January 2026:Antibiotic Therapy for Uncomplicated Acute Appendicitis: Ten-Year Follow-Up of the APPAC Randomized Clinical Trial
This long-term clinical study evaluates whether treating uncomplicated appendicitis with medication is a viable alternative to traditional surgery over a ten-year period. By tracking hundreds of patients, researchers found that while nearly 40% of those who took antibiotics eventually experienced a recurrence, the majority avoided surgery entirely without sacrificing their overall quality of life.
Gastroenterology February 2026: The Prevalence and Burden of Avoidant/Restrictive Food Intake Disorder Symptoms in Adults With Disorders of Gut-Brain Interaction: A Population-Based Study
This population-based study investigates the strong correlation between disorders of gut-brain interaction (DGBI) and avoidant/restrictive food intake disorder (ARFID) among the general adult population in the United Kingdom and United States. The researchers discovered that individuals suffering from digestive issues are significantly more likely to restrict their food intake, with the risk of di
Gastroenterology February 2026:The Disease Burden of Helicobacter pylori Beyond Gastric Cancer
While health policies often focus on the link between Helicobacter pylori and stomach cancer, this research highlights the massive global burden of other conditions caused by the bacteria, such as peptic ulcers and indigestion. By analyzing international data, the authors demonstrate that eradicating the infection could prevent millions of cases of illness, suggesting that current medical guidelin
Clinical Gastroenterology and Hepatology; January 2026 Long-Term Mortality After Cholecystectomy in a Nationwide Cohort of Swedish Individuals Between 1969 and 2016
This nationwide Swedish study investigated the long-term survival rates of nearly 160,000 patients who underwent gallbladder removal surgery over several decades. By comparing these patients to the general public, researchers discovered a distinct age-based disparity in mortality outcomes following the procedure. While older patients generally experienced lower mortality, those who had the surgery
Clinical Gastroenterology and Hepatology; January 2026 Comparative Effectiveness of Empiric Treatment for Helicobacter pylori in a Large, Diverse Population in the United States
This comprehensive study evaluates the success rates of various antibiotic combinations used to eliminate H. pylori infections within a diverse American population. The research highlights that four-drug regimens, specifically concomitant and bismuth-based quadruple therapies, serve as the most effective initial treatments and maintain their potency over time. Crucially, the data suggests that pri
Clinical Gastroenterology and Hepatology; January 2026 Diagnosis of Retrograde Cricopharyngeus Dysfunction Using High Resolution Impedance Manometry and Comparison With Control Subjects
This research investigates Retrograde Cricopharyngeus Dysfunction (R-CPD), a condition where the throat muscle fails to relax, making it impossible for a person to belch. By using advanced pressure-sensing technology during a sparkling water provocation test, scientists discovered that patients with this disorder maintain excessively high pressure in the upper esophageal sphincter, causing gas to
World J Gastroenterol . 2025 Aug Positioning and sequencing of advanced therapies in inflammatory bowel disease: A guide for clinical practice
This academic review explores the modern landscape of inflammatory bowel disease treatment, which has evolved from a limited selection of drugs to a diverse array of advanced biological and molecular therapies. As the number of available medications increases, clinicians face the growing challenge of optimizing the sequence and positioning of these treatments to manage complex patient cases effect
World J Gastroenterol . 2025 Jun 14 Exploring the gut-exercise link: A systematic review of gastrointestinal disorders in physical activity
This systematic review investigates the bidirectional relationship between physical activity and digestive well-being, highlighting how exercise can serve as both a remedy and a stressor for the gut. By synthesizing hundreds of studies, the authors demonstrate that moderate movement enhances intestinal motility and reduces inflammation, offering significant relief for chronic conditions like irrit
World J Gastroenterol . 2025 May 28 Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass
This text explores the intricate bidirectional relationship between metabolic liver disease and skeletal muscle health, illustrating how physical decline both mirrors and worsens hepatic damage. The author identifies sarcopenia and myosteatosis—the loss of muscle mass and the infiltration of fat into muscle tissue—as critical factors that drive insulin resistance and systemic inflammation, ultimat
Gastroenterology January 2026 Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External Validation
In a prospectively recruited cohort of 7239 patients hospitalized with cirrhosis (Chronic Liver Disease Evolution and Registry for Events and Decompensation [CLEARED]) from 115 centers across all 6 populated continents, it was determined that a random forest machine learning model significantly enhanced inpatient mortality prediction over other models and traditional logistic regression. This rand
Gastroenterology January 2026 The Natural History of Gastroesophageal Varices in Children With Portal Hypertension
This long-term study tracks how gastroesophageal varices evolve in children suffering from high blood pressure in the portal vein. The researchers discovered that internal conditions frequently deteriorate over time, with more than half of the subjects developing high-risk lesionswithin a decade of their first checkup. Young patients with biliary atresiawere identified as being at an especially hi
Gastroenterology January 2026 ly Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC
This research investigates how tracking the concentration and processing speed of infliximab can determine the success of emergency treatment for acute severe ulcerative colitis. By analyzing blood and stool samples, the study discovered that low drug levels and rapid clearance shortly after the first dose are strong predictors of treatment failure and the future need for surgery. The findings sug
Gastroenterology January 2026 Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study
This prospective study utilizes real-time electronic health data to confirm that newly diagnosed diabetes in older adults serves as a significant early warning sign for pancreatic cancer. By tracking patients over a three-year period, researchers discovered that while the overall risk is high, there are pronounced racial and ethnic disparities, with non-Hispanic White patients showing the highest
Gastroenterology January 2026Selective Urokinase Inhibition Plus Chemotherapy: A Novel Approach to Pancreatic Cancer Treatment via Enhanced Antitumor Immunity and Decreased Metastasis
Researchers have developed a promising new strategy to combat pancreatic cancer by using a specialized inhibitor called BB2–30F to block the uPA enzyme system, which typically drives tumor spread. By combining this inhibitor with traditional chemotherapy, the study demonstrated a significant ability to stunt primary tumor growth and, remarkably, eliminate visible distant metastasis in animal model
Skyrizi Overtakes Humira: “Product Hopping” Leaves Biosimilar Market in Limbo
Recent financial data reveals a significant shift in the pharmaceutical landscape as the drug Skyrizi has officially surpassed Humira in global sales, marking a pivotal transition for the manufacturer AbbVie. This change is driven by a strategy known as product hopping, where companies encourage patients to move from older medications facing generic competition to newer, patented treatments. While
3 Ustekinumab Biosimilars Launch on US Market
The year 2025 marks a transformative shift in the pharmaceutical landscape as multiple low-cost biosimilars enter the U.S. market to compete with the high-revenue drug Stelara. Following a series of legal delays and patent settlements, several pharmaceutical companies have launched alternative treatments for chronic inflammatory conditions, such as Crohn’s disease and plaque psoriasis. These new o
Wezlana: The First Stelara Biosimilar to Launch in the US
This text details the arrival of Wezlana, the first interchangeable biosimilarto the blockbuster drug Stelara, marking a shift toward more affordable treatment options for autoimmune and gastrointestinal diseases. By securing an interchangeability status, this new medication can be substituted by pharmacists without a provider's intervention, potentially increasing patient access while address
AGA Clinical Practice Update on Nonampullary Duodenal Lesions: Expert Review:
This expert review provides a comprehensive framework for the clinical management of nonampullary duodenal polyps, which are often discovered incidentally during routine medical exams. The text outlines essential diagnostic protocols, emphasizing the need to distinguish between benign mimics and true adenomas while carefully mapping a lesion's location relative to the major papilla. Because th
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 19
Gastro Hep Advances A Machine Learning Model to Predict Risk for Hepatocellular Carcinoma in Patients With Metabolic Dysfunction-Associated Steatotic Liver DiseaseVolume 3, Issue 4P498-5052024This study explored the use of machine learning (ML) models to predict the risk of hepatocellular carcinoma (HCC) in patients suffering from metabolic dysfunction-associated steatotic liver disease (MASLD),
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 18
Gastro Hep Advances The Microbiome in Quiescent Crohn’s Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan PathwaysVolume 3, Issue 2P167-1772024This research investigates how the gut's microbial community, or microbiome, differs in individuals with Crohn's disease (CD) who have persistent symptoms despite being in a state of quiescent disease (no inflammat
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 17
Gastro Hep Advances Dynamics of Virological and Clinical Response Parameters of Bulevirtide Treatment for Hepatitis D: Real-World DataVolume 3, Issue 3P353-3602024This study examines the real-world application of $\mathbf{bulevirtide}$, the first targeted treatment for $\mathbf{Hepatitis\ D\ virus\ (HDV)}$, using data from 15 patients. The research aimed to understand the timeline of patient impro
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 16
FROM Gastro Hep Advances Esophageal Symptoms and Lumbosacral Back PainVolume 3, Issue 2P292-2992024This study investigated a potential link between typical esophageal symptoms—such as heartburn, difficulty swallowing, and chest pain—and chronic lumbosacral back pain. Researchers compared patients referred for esophageal assessment with a control group undergoing routine colonoscopy, using questi
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 15
FROM Techniques and Innovations in Gastrointestinal EndoscopyClinical Efficacy and Safety of a Novel Stent for Fistula Management Following Sleeve GastrectomyVolume 26, Issue 1P12-202024This study explores the clinical efficacy and safety of a new stent design for managing fistulas following sleeve gastrectomy (SG), reflecting a broader shift from surgical to primarily endoscopic treatment methods
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 14
Techniques and Innovations in Gastrointestinal EndoscopyDevelopment and Validation of an Automated, Real-time Adenoma Detection Rate and Colonoscopy Quality Metrics CalculatorVolume 26, Issue 1P2-112024This study details the creation of a sophisticated, fully automated platformdesigned to efficiently measure the quality of colonoscopy procedures. Recognizing that a high-quality colonoscopy signif
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 13
Techniques and Innovations in Gastrointestinal EndoscopyMagnetic Compression Anastomosis for Esophageal Obstruction: Indications, Contraindications, Methodologies, and Technique StrategiesVolume 26, Issue 3P206-2152024This study evaluates Magnetic Compression Anastomosis (MCA) as a promising and novel technique for treating severe or refractory esophageal obstruction, offering an alternative to th
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 12
FROM Techniques and Innovations in Gastrointestinal EndoscopyRandomized Double-blind Sham-controlled Trial of a Novel Silicone-filled Endoscopically Placed Device for Weight LossVolume 26, Issue 1P21-292024This research details a randomized, double-blind, sham-controlled trialinvestigating a novel, endoscopically placed intragastric device called the TransPyloric Shuttle for treating Class I and I
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 11
FROM Techniques and Innovations in Gastrointestinal EndoscopyLimitations of the Location-Based and Polyp-Based Resect and Discard StrategiesVolume 26, Issue 3P237-2432024This study explored two new approaches, the Location-Based Resect and Discard (LBRD) and Polyp-Based Resect and Discard (PBRD) strategies, aimed at reducing the expense associated with colonoscopy screenings by minimizing the need
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 10
Clinical Gastroenterology and Hepatology Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn’s Disease (EXPLORER)Volume 22, Issue 7P1487-1496.E12July 2024The EXPLORER study investigated whether a triple combination therapy—specifically using vedolizumab, adalimumab, and methotrexate—could improve treatment outcomes for individuals with newly diagnosed, moderate-to-high-risk Croh
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 9
Clinical Gastroenterology and Hepatology Coconut Water Induces Clinical Remission in Mild to Moderate Ulcerative Colitis: Double-blind Placebo-controlled TrialThis research investigated whether coconut water (CW) could serve as an effective adjunct therapy for individuals with mild to moderate ulcerative colitis (UC), a condition it may help by manipulating the gut microbiome and reducing inflam
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 8
Clinical Gastroenterology and Hepatology Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to TreatmentVolume 22, Issue 5P994-1004.E10May 2024This large-scale European study characterized the presentation and treatment effectiveness for Type 1 Autoimmune Pancreatitis (AIP), a condition where the immune system attacks the pancreas. Analyzing data from over 700 adults, the res
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 7
Clinical Gastroenterology and Hepatology Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 IndividualsVolume 22, Issue 5P1037-1047.E9May 2024This prospective cohort study involving nearly 4,800 individuals investigated whether early detection of liver fibrosis encourages people to make healthier life choices, specifically focusing on those at risk for alcohol-re
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 6
Clinical Gastroenterology and Hepatology Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput SequencingVolume 22, Issue 2P259-270February 2024
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 5
Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022Volume 166, Issue 4, 605 - 619
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 4
Comparison of Vonoprazan Versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers THE NEXT ARTICLE IS FROM JOURNAL GastroenterologyVolume 167, Issue 4P778-787.E3September 2024
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 3
Metabolic Dysfunction–Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction Gastroenterology Volume 167, Issue 2, 357 - 367.e9
Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 2
Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled TrialVolume 166, Issue 4, 690 - 703
Top 20 high-impact clinical research articles of 2024 in Gastroenterology: Episode 1
Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 DiabetesWang, Lindsey et al.
